Vito S.
- Country
- Belgium
- Department
- Immunology-Allergology-Rheumatology
Research Overview
- (Summit) A Multi-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of the Safety and Efficacy of CGT9486 in Subjects with NonAdvanced Systemic Mastocytosis
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Long‑Term Safety and Tolerability of Benralizumab in Participants with HES, EGPA, or Severe Asthma Continuing Therapy After Prior Study (ROSY‑F Roll‑Over)
Data & Insights
Has run more than one trial at 98 of 227 partner sites.
Specializations
Mastocytosis Research
The investigator specializes in various forms of systemic mastocytosis, including advanced, indolent, and smoldering variants. Their research encompasses novel therapeutic approaches using targeted agents like avapritinib, elenestinib, and bezuclastinib.
- Advanced Systemic Mastocytosis (AdvSM)
- Indolent Systemic Mastocytosis (ISM)
- Non-Advanced Systemic Mastocytosis
Their work includes evaluation of combination therapies and long-term treatment outcomes in mastocytosis patients.
Mast Cell Disorders
The investigator focuses on various mast cell-related conditions and their therapeutic management. Their expertise extends to both monoclonal and non-monoclonal manifestations of these disorders.
- Mast Cell Activation Syndrome
- Hypereosinophilic Syndrome
- Chronic Spontaneous Urticaria
Their research includes novel therapeutic approaches targeting specific pathways involved in mast cell disorders.
Hematologic Conditions
The investigator's research portfolio includes studies in hematologic malignancies with a particular focus on conditions involving KIT alterations and bone marrow disorders.
- Myelofibrosis
- KIT-altered Hematologic Malignancies
- Systemic Hematologic Disorders
Their work encompasses innovative therapeutic strategies for various hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.